kras mutation and glutathion JCI Kinetic and Redox Characterization of
Kinetic and Redox Characterization of KRAS G12C Inhibition bioRxiv Overcoming resistance to drugs targeting KRASG12C mutation The mechanistic overview of vitamin C toxicity in cancer cells with Download Scientific Diagram Targeting KRAS Mutant Cancers with a Covalent G12C Specific Inhibitor: Cell The roles of KRAS in cancer metabolism, tumor microenvironment and clinical therapy PMC Targeting mutated GTPase KRAS in tumor therapies ScienceDirect
Pay in 4 interest-free payments of $7.10 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8




